CannTrust Holdings Inc (CNSX:TRST) Director Mark Litwin sold 244,750 shares of the business’s stock in a transaction that occurred on Tuesday, December 5th. The stock was sold at an average price of C$7.35, for a total value of C$1,798,912.50.

CannTrust Holdings Inc (CNSX TRST) traded up C$0.31 during mid-day trading on Friday, reaching C$7.75. The company had a trading volume of 278,458 shares, compared to its average volume of 18,495. CannTrust Holdings Inc has a 12-month low of C$1.69 and a 12-month high of C$7.84.

Separately, Canaccord Genuity boosted their price target on CannTrust from $7.25 to $9.50 in a research note on Monday.

ILLEGAL ACTIVITY WARNING: This piece of content was first published by American Banking News and is the property of of American Banking News. If you are viewing this piece of content on another site, it was copied illegally and reposted in violation of US and international copyright laws. The legal version of this piece of content can be read at

CannTrust Company Profile

CannTrust Holdings Inc is a Canada-based company, which produces pharmaceutical-grade medical cannabis for patients. The Company is a federally regulated licensed producer of medical cannabis products. The Company operates a hydroponic facility and an onsite laboratory for testing and research on the medical use of cannabis.

Receive News & Ratings for CannTrust Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CannTrust Holdings Inc and related companies with's FREE daily email newsletter.